The FDA has accepted for review the BLA for lerodalcibep to reduce LDL-C in patients with or high risk of ASCVD and primary hyperlipidemia.

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.

Artificial intelligence (AI) can improve detection of congenital heart defects (CHDs) on routine prenatal ultrasounds.

COVID-19 infection, compared with influenza, is associated with increased myocarditis rates among adults in the United States.

A study has found that, among women with breast cancer, aerobic exercise significantly decreases risk for cardiovascular disease.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.